P1190: EFFICACY AND SAFETY OF SELINEXOR COMBINING WITH R-CHOP IN THE TREATMENT OF NEWLY DIAGNOSED HIGH RISK (IPI 3-5) GCB SUBTYPE DLBCL PATIENTS: A MULTICENTER RETROSPECTIVE REAL-WORLD STUDY FROM CHINA.

• LI Zhi-Ming,
• Hang Yang,
• Yanxue Yin,
• Yajun LI,
• Shiyong Zhou,
• Peng Sun,
• Yu Wang,
• Lu Zhang,
• Hui Zhou,
• Huilai Zhang

Affiliations

LI Zhi-Ming

1 Dongfeng East Road, Internal medicine, Guang Zhou Shi, China

Hang Yang

1 Dongfeng East Road, Internal medicine, Guang Zhou Shi, China

Yanxue Yin

2 Huazhong University Science and Technology Tongji Medical College Affiliated Union Hospital State Administration of Traditional Chinese Medicine Traditional Chi, Hematology, Wu Han

Yajun LI

3 Hunan Cancer Hospital, Lymphoma & Hematology Department, Changsha, China

Shiyong Zhou

4 Tianjin Medical University Cancer Institute and Hospital, Department of Lymphoma, Tianjin, China

Peng Sun

1 Dongfeng East Road, Internal medicine, Guang Zhou Shi, China

Yu Wang

1 Dongfeng East Road, Internal medicine, Guang Zhou Shi, China

Lu Zhang

2 Huazhong University Science and Technology Tongji Medical College Affiliated Union Hospital State Administration of Traditional Chinese Medicine Traditional Chi, Hematology, Wu Han

Hui Zhou

3 Hunan Cancer Hospital, Lymphoma & Hematology Department, Changsha, China

Huilai Zhang

4 Tianjin Medical University Cancer Institute and Hospital, Department of Lymphoma, Tianjin, China